Calamos Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.7M | Sell |
|
|||||
|
2025
Q1 | $7.78M | Sell |
|
|||||
|
2024
Q4 | $12.6M | Sell |
|
|||||
|
2024
Q3 | $26.3M | Sell |
|
|||||
|
2024
Q2 | $43.4M | Sell |
|
|||||
|
2024
Q1 | $39.6M | Sell |
|
|||||
|
2023
Q4 | $33.5M | Sell |
|
|||||
|
2023
Q3 | $30.2M | Sell |
|
|||||
|
2023
Q2 | $26.9M | Sell |
|
|||||
|
2023
Q1 | $31.2M | Sell |
|
|||||
|
2022
Q4 | $31.1M | Sell |
|
|||||
|
2022
Q3 | $25.9M | Sell |
|
|||||
|
2022
Q2 | $29.9M | Buy |
|
|||||
|
2022
Q1 | $25.2M | Sell |
|
|||||
|
2021
Q4 | $25.6M | Buy |
|
|||||
|
2021
Q3 | $20.9M | Buy |
|
|||||
|
2021
Q2 | $18M | Buy |
|
|||||
|
2021
Q1 | $11.7M | Sell |
|
|||||
|
2020
Q4 | $18.5M | Sell |
|
|||||
|
2020
Q3 | $26.1M | Buy |
|
|||||
|
2020
Q2 | $22.7M | Buy |
|
|||||
|
2020
Q1 | $15.1M | Buy |
|
|||||
|
2019
Q4 | $1.57M | Buy |
|
|||||
|
2019
Q3 | $1.05M | Hold |
|
|||||
|
2019
Q2 | $1.04M | Hold |
|
|||||
|
2019
Q1 | $1.07M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $7.4M | Buy |
|